Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic

Despite FDA approval of nine new drugs for patients with acute myeloid leukemia (AML) in the United States over the last 4 years, AML remains a major area of unmet medical need among hematologic malignancies. In this review, we discuss the development of promising new molecular targeted approaches f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bewersdorf, Jan Philipp, Abdel-Wahab, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973851/
https://www.ncbi.nlm.nih.gov/pubmed/35318270
http://dx.doi.org/10.1101/gad.349368.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973851/
https://www.ncbi.nlm.nih.gov/pubmed/35318270
http://dx.doi.org/10.1101/gad.349368.122

Ejemplares similares